Dr. Linda Duska, MD
Claim this profileUniversity of Virginia Cancer Center
Expert in Ovarian Cancer
Expert in Cancer
24 reported clinical trials
37 drugs studied
About Linda Duska, MD
Education:
- Obtained MD from the University of Virginia School of Medicine in 1995.
- Completed Residency in Obstetrics and Gynecology at the University of Virginia Health System in 2000.
- Finished Fellowship in Gynecologic Oncology at the University of Virginia Health System in 2003.
Experience:
- Currently a Professor of Obstetrics and Gynecology at the University of Virginia School of Medicine.
- Serves as the Director of the Division of Gynecologic Oncology at the University of Virginia Cancer Center.
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
HRD positive
2Cancer
Global LeaderStage IV
Stage III
BRCA1 negative
Affiliated Hospitals
Clinical Trials Linda Duska, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
More about Linda Duska, MD
Clinical Trial Related4 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Linda Duska, MD has experience with
- Paclitaxel
- Bevacizumab
- Carboplatin
- Niraparib
- Dostarlimab
- Oregovomab
Breakdown of trials Linda Duska, MD has run
Ovarian Cancer
Cancer
Ovarian Tumors
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Linda Duska, MD specialize in?
Linda Duska, MD focuses on Ovarian Cancer and Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Linda Duska, MD currently recruiting for clinical trials?
Yes, Linda Duska, MD is currently recruiting for 10 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Linda Duska, MD has studied deeply?
Yes, Linda Duska, MD has studied treatments such as Paclitaxel, Bevacizumab, Carboplatin.
What is the best way to schedule an appointment with Linda Duska, MD?
Apply for one of the trials that Linda Duska, MD is conducting.
What is the office address of Linda Duska, MD?
The office of Linda Duska, MD is located at: University of Virginia Cancer Center, Charlottesville, Virginia 22903 United States. This is the address for their practice at the University of Virginia Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.